personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
In November’s issue of The Small Molecule Manufacturer, industry experts discuss best practices for handling HPAPIs in our cover feature. We also explore how 3D printing can be used to improve therapeutic options for the blind and visually impaired in the Next Big Thing, as well as how drug developers can best handle solubility-challenged molecules. And we sit down with Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia, who explains how the COVID-19 pandemic has affected her first year at the company.